39
Views
3
CrossRef citations to date
0
Altmetric
Anatomical Pathology

Differential expression and localisation of gasdermin-like (GSDML), a novel member of the cancer-associated GSDMDC protein family, in neoplastic and non-neoplastic gastric, hepatic, and colon tissues

, , &
Pages 13-24 | Received 12 Jul 2006, Accepted 07 May 2007, Published online: 06 Jul 2009

References

  • Bateman A, Birney E, Cerruti L, et al. The pfam protein families database. Nucleic Acids Res 2002; 30: 276–80
  • Thompson D A, Weigel R J. Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas. Eur J Biochem 1998; 252: 169–77
  • Van Laer L, Huizing E H, Verstreken M, et al. Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet 1998; 20: 194–7
  • Maeda Y, Fukushima K, Kasai N, Maeta M, Nishizaki K. Quantification of TECTA and DFNA5 expression in the developing mouse cochlea. Neuroreport 2001; 12: 3223–6
  • Busch-Nentwich E, Söllner C, Roehl H, Nicolson T. The deafness gene dfna5 is crucial for ugdh expression and HA production in the developing ear of zebrafish. Development 2004; 131: 943–51
  • Bischoff A M, Luijendijk M W, Huygen P L, et al. A novel mutation identified in the DFNA5 gene in a Dutch family: a clinical and genetic evaluation. Audiol Neurootol 2004; 9: 34–46
  • Van Laer L, Vrijens K, Thys S, et al. DFNA5: hearing impairment exon instead of hearing impairment gene?. J Med Genet 2004; 41: 401–6
  • Yu C, Meng X, Zhang S, Zhao G, Hu L, Kong X. A 3-nucleotide deletion in the polypyrimidine tract of intron 7 of the DFNA5 gene causes nonsyndromic hearing impairment in a Chinese family. Genomics 2003; 82: 575–9
  • Gregan J, Van Laer L, Lieto L D, Van Camp G, Kearsey S E. A yeast model for the study of human DFNA5, a gene mutated in nonsyndromic hearing impairment. Biochim Biophys Acta 2003; 1638: 179–86
  • Grottke C, Mantwill K, Dietel M, Schadendorf D, Lage H. Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs. Int J Cancer 2000; 88: 535–46
  • Lage H, Helmbach H, Grottke C, Dietel M, Schadendorf D. DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells. FEBS Lett 2001; 494: 54–59
  • Akino K, Toyota M, Ogi K, Itoh F, Imai K, Tokino T. Identification of differentially methylated sequences in gastric cancer by methylated CpG island amplification. Proc AACR 2003; 44: 2206
  • Watabe K, Ito A, Asada H, et al. Structure, expression and chromosome mapping of MLZE, a novel gene which is preferentially expressed in metastatic melanoma cells. Jpn J Cancer Res 2001; 92: 140–51
  • Saeki N, Kuwahara Y, Sasaki H, Satoh H, Shiroishi T. Gasdermin (Gsdm) localizing to mouse Chromosome 11 is predominantly expressed in upper gastrointestinal tract but significantly suppressed in human gastric cancer cells. Mamm Genome 2000; 11: 718–24
  • Runkel F, Marquardt A, Stoeger C, et al. The dominant alopecia phenotypes Bareskin, Rex-denuded, and Reduced Coat 2 are caused by mutations in gasdermin 3. Genomics 2004; 84: 824–3
  • Lunny D P, Weed E, Nolan P M, Marquardt A, Augustin M, Porter R M. Mutations in gasdermin 3 cause aberrant differentiation of the hair follicle and sebaceous gland. J Invest Dermatol 2005; 124: 615–21
  • Katoh M, Katoh M. Evolutionary recombination hotspot around GSDML-GSDM locus is closely linked to the oncogenomic recombination hotspot around the PPP1R1B-ERBB2-GRB7 amplicon. Int J Oncol 2004; 24: 757–63
  • Katoh M, Katoh M. Identification and characterization of human ZPBP-like gene in silico. Int J Mol Med 2003; 12: 399–404
  • Katoh M, Katoh M. Identification and characterization of human DFNA5L, mouse Dfna5l, and rat Dfna5l genes in silico. Int J Oncol 2004; 25: 765–70
  • Kokkola A, Monni O, Puolakkainen P, et al. 17q12–21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparitive genomic hybridization study. Genes Chromosomes Cancer 1997; 20: 38–43
  • Sakakura C, Mori T, Sakabe T, et al. Gains, losses and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999; 24: 299–305
  • Nishida N, Nishimura T, Ito T, Komeda T, Fukuda Y, Nakao K. Chromosomal instability and human hepatocarcinogenesis. Histol Histopathol 2003; 18: 897–909
  • Wang G, Zhao Y, Liu X, et al. Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma. Genes Chromosomes Cancer 2001; 31: 221–7
  • Garcia-Patino E, Gomendio B, Lleonart M, et al. Loss of heterozygosity in the region including the BRCA1 gene on 17q in colon cancer. Cancer Genet Cytogenet 1998; 104: 119–23
  • Knosel T, Petersen S, Schwabe H, et al. Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases. Virchows Arch 2002; 440: 187–94
  • Knuutila S, Autio K, Aalto Y. Online access to CGH data of DNA sequence copy number changes. Am J Pathol 2000; 157: 689
  • Rost B. PHD: predicting one-dimensional protein structure by profile-based neural networks. Meth Enzymol 1996; 266: 525–39
  • Nakai K, Horton P. PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem Sci 1999; 24: 34–36

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.